Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCRELIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCRELIZUMAB: Safety Overview

Metric NYSTATIN\TRIAMCINOLONE ACETONIDE OCRELIZUMAB
Total FAERS Reports 164 56,186
Deaths Reported 0 1,406
Death Rate N/A 2.5%
Hospitalizations 0 10,364
Average Patient Age 62.3 yrs 47.2 yrs
% Female Patients 69.0% 72.5%
Manufacturer N/A Genentech, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription